P2857 increase in pulse rate with semaglutide did not result in increased adverse cardiac events in subjects with type 2 diabetes in the SUSTAIN 6 cardiovascular outcomes trial
Segn datos obtenidos de la Federacin Internacional de Diabetes, aproximadamente 537 millones de adultos de entre 20 y 79 aos, viven con diabetes en el mundo
Scientists are increasingly exploring whether medications already used for Type 2 diabetes mellitus and obesity could help reduce cravings and substance dependence
Even if there are doses remaining
BMC Endocrine Disorders, 19(1), 106
Adjacent innovations shown at the event, such as water-free stick formats and melt-in-mouth, directly-dosed powders, point the same direction: reduce the volume and the effort a user has to tolerate